These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 14607925)

  • 21. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
    Mueller CM; Scott DW
    J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
    Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
    Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
    Küenzi P; Schneider P; Dobbelaere DA
    J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway.
    Lyubchenko T; dal Porto J; Cambier JC; Holers VM
    J Immunol; 2005 Mar; 174(6):3264-72. PubMed ID: 15749857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
    Roberts T; Snow EC
    J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells.
    Herold MJ; Kuss AW; Kraus C; Berberich I
    J Immunol; 2002 Apr; 168(8):3902-9. PubMed ID: 11937545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.
    Boehrer S; Brieger A; Schaaf S; Kukoc-Zivojnov N; Nowak D; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Leuk Lymphoma; 2004 Jul; 45(7):1445-51. PubMed ID: 15359646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
    Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
    J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
    Starcevic SL; Elferink C; Novak RF
    J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.
    Owyang AM; Tumang JR; Schram BR; Hsia CY; Behrens TW; Rothstein TL; Liou HC
    J Immunol; 2001 Nov; 167(9):4948-56. PubMed ID: 11673501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
    Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
    Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1.
    Gatto D; Pfister T; Jegerlehner A; Martin SW; Kopf M; Bachmann MF
    J Exp Med; 2005 Mar; 201(6):993-1005. PubMed ID: 15767369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
    Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
    Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.